New Type B Isolates of Epstein--Barr Virus from Burkitt's Lymphoma and from Normal Individuals in Endemic Areas
The DOI matches its Crossref record.
Abstract
All Epstein-Barr virus (EBV) isolates can be classified as type A or type B depending upon the identity of their EBV nuclear antigen (EBNA) 2 protein. The great majority of isolates examined to date encode an EBNA 2A protein like that of the reference type A strain B95-8. Type B virus strains, encoding an antigenically distinct EBNA 2B protein, have as yet only been rescued from rare Burkitt's lymphoma (BL) cell lines of African origin (Jijoye, AG876). Our recent finding that type B isolates are less efficient than type A in in vitro transformation assays prompted us to determine (i) the relative contribution the two types of virus make to the incidence of BL in endemic areas of Africa (Kenya) and New Guinea and (ii) the relative incidence of infection with these two types in the normal population in these same areas. On the first point, EBNA 2 gene typing using specific DNA probes showed that four of ten recently established Kenyan BL cell lines and two of four BL cell lines from New Guinea carried type B virus isolates. To address the second point, spontaneous lymphoblastoid cell lines were established from the blood of normal virus carriers and typed for EBNA 2 at the protein level; a significant proportion (greater than 20%) of the normal population in both the above BL-endemic areas were infected with type B isolates. This is the first indication of the widespread nature of type B virus infection in any community and the first isolation of such viruses from a non-BL source. The reproducible size of the EBNA 2B protein encoded by all type B isolates irrespective of their geographical origin, and of the EBNA 1 protein encoded by all type B isolates from one area, contrasted markedly with the extreme variability in the size both of EBNA 2A and of EBNA 1 seen generally among type A isolates. This suggests that the number of type B virus strains in existence worldwide could be quite limited. Most importantly, the data suggest that type B viruses, despite their relatively poor performance in in vitro transformation assays, can contribute at least as efficiently as can type A viruses to the pathogenesis of BL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Thompson, M. P., & Kurzrock, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0670-3 · Cited by 786
Epstein–Barr virus in the pathogenesis of NPC
Raab-Traub, N. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x0200086x · Cited by 562
The epidemiology of multiple sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 514
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes
Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4084-4092.1990 · Cited by 497
Self-citationThe Pathogenesis of Burkitt's Lymphoma
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 466
Metadata
- Authors
- Young, L. S., Yao, Q. Y., Rooney, C. M., Sculley, T. B., Moss, D. J., Rupani, H., Laux, G., Bornkamm, G. W., & Rickinson, A. B.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 1987-11-01
- Volume
- 68
- Issue
- 11
- Pages
- 2853-2862
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W2063175140
- Cited by
- 204
- References
- 0
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Type B Isolates of Epstein--Barr Virus from Burkitt's Lymphoma and from Normal Individuals in Endemic Areas. https://app.cochat.ai/papers/10.1099/0022-1317-68-11-2853
- The paper
- Young, L. S., Yao, Q. Y., Rooney, C. M., Sculley, T. B., Moss, D. J., Rupani, H., Laux, G., Bornkamm, G. W., & Rickinson, A. B. (1987). New Type B Isolates of Epstein--Barr Virus from Burkitt's Lymphoma and from Normal Individuals in Endemic Areas. Journal of General Virology. https://doi.org/10.1099/0022-1317-68-11-2853
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.